CollPlant is a regenerative medicine company leveraging its proprietary, plant based recombinant human collagen rhCollagen technology for the development and commercialization of tissue repair products, initially for D Bio printing of tissue and organs, for orthobiologics and advanced wound care markets. The Company s cutting edge technology is designed to generate and process proprietary rhCollagen, among other patent protected recombinant proteins. Given that CollPlant s rhCollagen is identical to the type I collagen produced by the human body, it offers significant advantages compared to currently marketed tissue derived collagen, including improved biofunctionality, superior homogeneity and reduced risk of immune response. The Company s broad development pipeline includes biomaterials indicated for orthopedics and advanced wound healing. Lead products include: Vergenix R STR Soft Tissue Repair Matrix , for the treatment of tendinopathy and Vergenix R FG Flowable Gel wound filler, for treatment of acute and chronic wounds. CollPlant s business strategy includes proprietary development and manufacture of tissue repair products and their commercialization and distribution, together with leading third parties, alongside alliances with leading companies for joint development, manufacture and marketing of additional products.
Quote | CollPlant Holdings Ltd. (NASDAQ:CLGN)
Last: | $5.26 |
---|---|
Change Percent: | 0.19% |
Open: | $5.19 |
Close: | $5.26 |
High: | $5.27 |
Low: | $5.19 |
Volume: | 4,270 |
Last Trade Date Time: | 04/22/2024 03:00:00 am |
News | CollPlant Holdings Ltd. (NASDAQ:CLGN)
2024-04-07 10:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-04 13:15:24 ET CollPlant Biotechnologies Ltd. (CLGN) Q4 2023 Earnings Conference Call April 04, 2024, 10:00 AM ET Company Participants Dory Kurowski - Investor Relations Yehiel Tal - Chief Executive Officer Eran Rotem - Deputy Chief Executive Officer and ...
Message Board Posts | CollPlant Holdings Ltd. (NASDAQ:CLGN)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $CLGN News Article - Collplant Biotechnologies Announces Full-Year Financial Results Fo | whytestocks | investorshangout | 03/29/2023 12:05:49 PM |
whytestocks: $CLGN News Article - CollPlant Announces Successful Pre-Clinical Results in 3D Bioprint | whytestocks | investorshangout | 01/04/2023 3:55:46 PM |
whytestocks: $CLGN News Article - CollPlant Biotechnologies Provides Business Updates and Second Qua | whytestocks | investorshangout | 08/25/2022 4:31:08 PM |
whytestocks: $CLGN News Article - CollPlant Biotechnologies Provides Business Updates and Fiscal Yea | whytestocks | investorshangout | 03/24/2022 12:11:01 PM |
Shares of CollPlant BioTechnologies (NASDAQ:$CLGN), which engages in | midastouch017 | investorshub | 12/28/2021 5:45:16 AM |
News, Short Squeeze, Breakout and More Instantly...
CollPlant Holdings Ltd. Company Name:
CLGN Stock Symbol:
NASDAQ Market:
2024-04-07 10:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-28 11:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-02-26 02:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...